Middle East Pharmaceutical Industries Company Statistics

Total Valuation

Middle East Pharmaceutical Industries Company has a market cap or net worth of SAR 2.46 billion. The enterprise value is 2.52 billion.

Market Cap	2.46B
Enterprise Value	2.52B

Important Dates

The last earnings date was Wednesday, November 6, 2024.

Earnings Date	Nov 6, 2024
Ex-Dividend Date	n/a

Share Statistics

Middle East Pharmaceutical Industries Company has 20.00 million shares outstanding. The number of shares has decreased by -0.00% in one year.

Current Share Class	n/a
Shares Outstanding	20.00M
Shares Change (YoY)	-0.00%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	25.20%
Owned by Institutions (%)	0.10%
Float	6.00M

Valuation Ratios

The trailing PE ratio is 30.53 and the forward PE ratio is 25.06.

PE Ratio	30.53
Forward PE	25.06
PS Ratio	6.34
PB Ratio	7.53
P/TBV Ratio	n/a
P/FCF Ratio	58.69
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 25.07, with an EV/FCF ratio of 60.12.

EV / Earnings	31.27
EV / Sales	6.50
EV / EBITDA	25.07
EV / EBIT	27.52
EV / FCF	60.12

Financial Position

The company has a current ratio of 2.23, with a Debt / Equity ratio of 0.23.

Current Ratio	2.23
Quick Ratio	1.31
Debt / Equity	0.23
Debt / EBITDA	0.73
Debt / FCF	1.76
Interest Coverage	19.68

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	n/a
Revenue Per Employee	713,046
Profits Per Employee	148,149
Employee Count	543
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	131.80
200-Day Moving Average	n/a
Relative Strength Index (RSI)	33.23
Average Volume (20 Days)	59,975

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Middle East Pharmaceutical Industries Company had revenue of SAR 387.18 million and earned 80.44 million in profits. Earnings per share was 4.02.

Revenue	387.18M
Gross Profit	243.93M
Operating Income	91.42M
Pretax Income	86.43M
Net Income	80.44M
EBITDA	100.35M
EBIT	91.42M
Earnings Per Share (EPS)	4.02

Full Income Statement

Balance Sheet

The company has 13.80 million in cash and 73.58 million in debt, giving a net cash position of -59.78 million or -2.99 per share.

Cash & Cash Equivalents	13.80M
Total Debt	73.58M
Net Cash	-59.78M
Net Cash Per Share	-2.99
Equity (Book Value)	326.19M
Book Value Per Share	16.31
Working Capital	178.77M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 61.54 million and capital expenditures -19.70 million, giving a free cash flow of 41.84 million.

Operating Cash Flow	61.54M
Capital Expenditures	-19.70M
Free Cash Flow	41.84M
FCF Per Share	2.09

Full Cash Flow Statement

Margins

Gross margin is 63.00%, with operating and profit margins of 23.61% and 20.78%.

Gross Margin	63.00%
Operating Margin	23.61%
Pretax Margin	22.32%
Profit Margin	20.78%
EBITDA Margin	25.92%
EBIT Margin	23.61%
FCF Margin	10.81%

Dividends & Yields

This stock pays an annual dividend of 1.50, which amounts to a dividend yield of 1.22%.

Dividend Per Share	1.50
Dividend Yield	1.22%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	33.56%
Buyback Yield	0.00%
Shareholder Yield	1.22%
Earnings Yield	3.28%
FCF Yield	1.70%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Middle East Pharmaceutical Industries Company has an Altman Z-Score of 12.24.

Altman Z-Score	12.24
Piotroski F-Score	n/a